These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2469139)

  • 1. Exacerbation of tallysomycin toxicity in rats by concurrent exposure to sublethal hyperoxia.
    Coursin DB; Cihla HP; Oberley TD
    Toxicology; 1989 Apr; 55(1-2):225-37. PubMed ID: 2469139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tallysomycin S10b: experimental antitumor activity and toxicity.
    Schurig JE; Rose WC; Hirth RS; Schlein A; Huftalen JB; Florczyk AP; Bradner WT
    Cancer Chemother Pharmacol; 1984; 13(3):164-70. PubMed ID: 6207948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-lethal hyperoxic potentiation of lung disease in the rat following subcutaneous administration of bleomycin.
    Coursin DB; Cihla HP
    Toxicology; 1988 Dec; 53(1):45-55. PubMed ID: 2462289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in effects of immediate and delayed hyperoxia exposure on bleomycin-induced pulmonary injury.
    Tryka AF; Godleski JJ; Brain JD
    Cancer Treat Rep; 1984 May; 68(5):759-64. PubMed ID: 6202406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxical effects of bleomycin and heavy water (D2O) in mice.
    Gaeng DP; Geiser M; Cruz-Orive LM; Larsen SE; Schaffner T; Laissue JA; Altermatt HJ
    Int J Cancer; 1995 Sep; 62(6):784-90. PubMed ID: 7558431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible modulatory role of nitric oxide in lung toxicity induced in rats by chronic administration of bleomycin.
    El-Khatib AS
    Chemotherapy; 2002 Dec; 48(5):244-51. PubMed ID: 12476041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary toxicity of the combination of bleomycin and peplomycin--an experimental study in rats.
    Mall G; Burkhardt A
    Cancer Chemother Pharmacol; 1991; 28(5):357-60. PubMed ID: 1717172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The toxicological evaluation of tallysomycin s10b--biosynthetic tallysomycin derivative.
    Buroker RA; Comereski CR; Barnett D; Hirth RS; Madissoo H; Hottendorf GH
    Drug Chem Toxicol; 1984; 7(3):259-72. PubMed ID: 6203697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2001 Jul; (499):7-340. PubMed ID: 12087422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary toxicity after treatment with bleomycin alone or in combination with hyperoxia. Studies in the rat.
    Blom-Muilwijk MC; Vriesendorp R; Veninga TS; Hofstra W; Sleyfer DT; Wieringa RA; Konings AW
    Br J Anaesth; 1988 Jan; 60(1):91-7. PubMed ID: 2447926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute pulmonary toxicity of bleomycin: DNA scission and matrix protein mRNA levels in bleomycin-sensitive and -resistant strains of mice.
    Harrison JH; Hoyt DG; Lazo JS
    Mol Pharmacol; 1989 Aug; 36(2):231-8. PubMed ID: 2475758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptation to chronic hyperoxia. Biochemical effects and the response to subsequent lethal hyperoxia.
    Coursin DB; Cihla HP; Will JA; McCreary JL
    Am Rev Respir Dis; 1987 May; 135(5):1002-6. PubMed ID: 3579000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 0.25 ppm ozone exposure on pulmonary damage induced by bleomycin.
    Oyarzún M; Dussaubat N; González S
    Biol Res; 2005; 38(4):353-8. PubMed ID: 16579517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbon black nanoparticles enhance bleomycin-induced lung inflammatory and fibrotic changes in mice.
    Kamata H; Tasaka S; Inoue K; Miyamoto K; Nakano Y; Shinoda H; Kimizuka Y; Fujiwara H; Ishii M; Hasegawa N; Takamiya R; Fujishima S; Takano H; Ishizaka A
    Exp Biol Med (Maywood); 2011 Mar; 236(3):315-24. PubMed ID: 21427237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of bleomycin-induced lung injury and oxidative stress by N-acetylcysteine plus deferoxamine.
    Teixeira KC; Soares FS; Rocha LG; Silveira PC; Silva LA; Valença SS; Dal Pizzol F; Streck EL; Pinho RA
    Pulm Pharmacol Ther; 2008; 21(2):309-16. PubMed ID: 17904883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of acute lung injury after the combination of intravenous bleomycin and exposure to hyperoxia in rats.
    Hay JG; Haslam PL; Dewar A; Addis B; Turner-Warwick M; Laurent GJ
    Thorax; 1987 May; 42(5):374-82. PubMed ID: 2443992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potentiation of the antitumor activity but not toxicity of bleomycin by 3-aminobenzamide.
    Pan QC; Guo HY
    J Antibiot (Tokyo); 1989 Dec; 42(12):1860-8. PubMed ID: 2482841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of granulocyte colony-stimulating factor (G-CSF) on bleomycin-induced lung injury of varying severity.
    Adachi K; Suzuki M; Sugimoto T; Yorozu K; Takai H; Uetsuka K; Nakayama H; Doi K
    Toxicol Pathol; 2003; 31(6):665-73. PubMed ID: 14585735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of intra-amniotic endotoxin priming plus hyperoxic exposure on the expression of vascular endothelial growth factor and its receptors in lungs of preterm newborn rats].
    Wang W; Wei W; Ning Q; Luo XP
    Zhonghua Er Ke Za Zhi; 2007 Jul; 45(7):533-8. PubMed ID: 17953812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tallysomycin S10b--a phase I trial.
    Sørensen PG; Pedersen H; Clausen HV; Hansen HH
    Cancer Chemother Pharmacol; 1989; 24(2):113-6. PubMed ID: 2471602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.